Successful Treatment of Leuconostoc Bacteremia in a Neutropenic Patient with Tigecycline

Trupti Patel; Aoife Molloy; Robin Smith; Indran Balakrishnan

doi:10.4081/idr.2012.e31

You are currently viewing a new version of our website. To view the old version click .

Infectious Disease Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Case Report

27 April 2012

Successful Treatment of Leuconostoc Bacteremia in a Neutropenic Patient with Tigecycline

and

Department of Microbiology, Royal Free Hospital NHS Foundation Trust, London, UK

Department of Infectious Diseases, Ealing Hospital, Ealing Hospital NHS Trust, Southall, UK

Author to whom correspondence should be addressed.

Infect. Dis. Rep.2012, 4(2), e31;https://doi.org/10.4081/idr.2012.e31

Version Notes

Order Reprints

Abstract

Leuconostoc lactis is a recognised cause of infection in immunocompromised hosts. It is intrinsically resistant to multiple antibiotics and treatment options may be limited. We report the safe and effective use of tigecycline in the treatment of Leuconostoc catheter-related line sepsis in a neutropenic patient. To our knowledge, this is the first reported case of successful use of tigecycline for Leuconostoc bacteremia.

Keywords:

Leuconostoc; tigecycline; bacteremia; immunocompromise; neutropenia

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Kinetics of HIV-1 in Cerebrospinal Fluid and Plasma in Cryptococcal Meningitis

Prosthetic Valve Endocarditis Caused by Pasteurella in a Penicillin Allergic Patient: Challenges in Diagnosis and Treatment